1. Home
  2. VRAX vs PBM Comparison

VRAX vs PBM Comparison

Compare VRAX & PBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRAX
  • PBM
  • Stock Information
  • Founded
  • VRAX 2013
  • PBM 1994
  • Country
  • VRAX United Kingdom
  • PBM Canada
  • Employees
  • VRAX N/A
  • PBM N/A
  • Industry
  • VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • PBM
  • Sector
  • VRAX Health Care
  • PBM
  • Exchange
  • VRAX Nasdaq
  • PBM NYSE
  • Market Cap
  • VRAX 7.3M
  • PBM 5.3M
  • IPO Year
  • VRAX 2022
  • PBM N/A
  • Fundamental
  • Price
  • VRAX $1.90
  • PBM $1.40
  • Analyst Decision
  • VRAX
  • PBM
  • Analyst Count
  • VRAX 0
  • PBM 0
  • Target Price
  • VRAX N/A
  • PBM N/A
  • AVG Volume (30 Days)
  • VRAX 282.7K
  • PBM 417.9K
  • Earning Date
  • VRAX 02-05-2025
  • PBM 02-02-2025
  • Dividend Yield
  • VRAX N/A
  • PBM N/A
  • EPS Growth
  • VRAX N/A
  • PBM N/A
  • EPS
  • VRAX N/A
  • PBM N/A
  • Revenue
  • VRAX $84,872.00
  • PBM N/A
  • Revenue This Year
  • VRAX $5,169.18
  • PBM N/A
  • Revenue Next Year
  • VRAX $66.97
  • PBM N/A
  • P/E Ratio
  • VRAX N/A
  • PBM N/A
  • Revenue Growth
  • VRAX 7.03
  • PBM N/A
  • 52 Week Low
  • VRAX $0.60
  • PBM $1.15
  • 52 Week High
  • VRAX $9.00
  • PBM $323.25
  • Technical
  • Relative Strength Index (RSI)
  • VRAX 49.13
  • PBM 41.45
  • Support Level
  • VRAX $1.58
  • PBM $1.15
  • Resistance Level
  • VRAX $2.10
  • PBM $1.59
  • Average True Range (ATR)
  • VRAX 0.25
  • PBM 0.20
  • MACD
  • VRAX 0.01
  • PBM 0.03
  • Stochastic Oscillator
  • VRAX 47.88
  • PBM 27.53

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.

About PBM PSYENCE BIOMEDICAL LTD

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Share on Social Networks: